Skip to main content
. 2022 Mar 18;13:862394. doi: 10.3389/fendo.2022.862394

Figure 5.

Figure 5

Effect of dapagliflozin (Dapa) and liraglutide (Lira) or their combination on protein levels of (A) tissue IL-1β and (B) tissue IL-6. Data are represented as mean ± SE, n = 5. ** significance in comparison with control group at p < 0.01, **** at p < 0.0001, ## significance in comparison with diabetic group at p < 0.01, #### at p < 0.0001, ~~~~ significance in comparison with DM+Dapa at p < 0.0001, $$$$ significance in comparison with DM+Lira group at p < 0.0001.